Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance

[1]  F. Nosten,et al.  Population Parameters Underlying an Ongoing Soft Sweep in Southeast Asian Malaria Parasites , 2016, Molecular biology and evolution.

[2]  C. Rogier,et al.  A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms. , 2016, The New England journal of medicine.

[3]  Zbynek Bozdech,et al.  Declining Efficacy of Artemisinin Combination Therapy Against P. Falciparum Malaria on the Thai–Myanmar Border (2003–2013): The Role of Parasite Genetic Factors , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  F. Nosten,et al.  Why are there so many independent origins of artemisinin resistance in malaria parasites? , 2016, bioRxiv.

[5]  J. Barnwell,et al.  Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana. , 2016, The Journal of infectious diseases.

[6]  J. Augereau,et al.  Plasmodium falciparum: multifaceted resistance to artemisinins , 2016, Malaria Journal.

[7]  Nicholas P. J. Day,et al.  Genomic epidemiology of artemisinin resistant malaria. , 2016, eLife.

[8]  M. Fay,et al.  Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. , 2016, The Lancet. Infectious diseases.

[9]  R. Sauerwein,et al.  PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites , 2016, Antimicrobial Agents and Chemotherapy.

[10]  Brian L Browning,et al.  Genotype Imputation with Millions of Reference Samples. , 2016, American journal of human genetics.

[11]  D. Conway,et al.  Population Structure Shapes Copy Number Variation in Malaria Parasites , 2015, Molecular biology and evolution.

[12]  F. Nosten,et al.  A Brief History of Qinghaosu , 2015, Trends in parasitology.

[13]  G. Johnston,et al.  Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter , 2015, Molecular microbiology.

[14]  S. Meshnick,et al.  Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[15]  S. Schaffner,et al.  Modeling malaria genomics reveals transmission decline and rebound in Senegal , 2015, Proceedings of the National Academy of Sciences.

[16]  Scott Emrich,et al.  A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria , 2015, Nature.

[17]  Zbynek Bozdech,et al.  TARGETING THE CELL STRESS RESPONSE OF PLASMODIUM FALCIPARUM TO OVERCOME ARTEMISININ RESISTANCE , 2015 .

[18]  B. Cooper,et al.  Defining the In Vivo Phenotype of Artemisinin-Resistant Falciparum Malaria: A Modelling Approach , 2015, PLoS medicine.

[19]  Gilean McVean,et al.  Genetic architecture of artemisinin-resistant Plasmodium falciparum , 2015, Nature Genetics.

[20]  John C. Tan,et al.  Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. , 2015, The Journal of infectious diseases.

[21]  D. Fidock,et al.  K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.

[22]  Huaiyu Mi,et al.  The InterPro protein families database: the classification resource after 15 years , 2014, Nucleic Acids Res..

[23]  Mihir Kekre,et al.  Generation of Antigenic Diversity in Plasmodium falciparum by Structured Rearrangement of Var Genes During Mitosis , 2014, PLoS genetics.

[24]  Tami D. Lieberman,et al.  Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance , 2014, Proceedings of the National Academy of Sciences.

[25]  D. Kwiatkowski,et al.  Spread of artemisinin resistance in Plasmodium falciparum malaria. , 2014, The New England journal of medicine.

[26]  Stephen D. Turner,et al.  qqman: an R package for visualizing GWAS results using Q-Q and manhattan plots , 2014, bioRxiv.

[27]  J. Crump,et al.  Evaluation of In-Hospital Management for Febrile Illness in Northern Tanzania before and after 2010 World Health Organization Guidelines for the Treatment of Malaria , 2014, PloS one.

[28]  Matthew Fraser,et al.  InterProScan 5: genome-scale protein function classification , 2014, Bioinform..

[29]  B. Genton,et al.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.

[30]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[31]  Robert W. Sauerwein,et al.  Targeting Plasmodium PI(4)K to eliminate malaria , 2013, Nature.

[32]  Saorin Kim,et al.  Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. , 2013, The Lancet. Infectious diseases.

[33]  Gilean McVean,et al.  Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia , 2013, Nature Genetics.

[34]  Ning Ma,et al.  BLAST: a more efficient report with usability improvements , 2013, Nucleic Acids Res..

[35]  F. Nosten,et al.  Genetic Evaluation of the Performance of Malaria Parasite Clearance Rate Metrics , 2013, The Journal of infectious diseases.

[36]  Geoffrey L. Johnston,et al.  Mitotic Evolution of Plasmodium falciparum Shows a Stable Core Genome but Recombination in Antigen Families , 2013, PLoS genetics.

[37]  François Nosten,et al.  Population genetic correlates of declining transmission in a human pathogen , 2012, Molecular ecology.

[38]  J. Le bras,et al.  Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000–2011 , 2013, Malaria Journal.

[39]  Joana C. Silva,et al.  Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia , 2012, Proceedings of the National Academy of Sciences.

[40]  Pardis C Sabeti,et al.  Sequence-based association and selection scans identify drug resistance loci in the Plasmodium falciparum malaria parasite , 2012, Proceedings of the National Academy of Sciences.

[41]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[42]  M. Stephens,et al.  Genome-wide Efficient Mixed Model Analysis for Association Studies , 2012, Nature Genetics.

[43]  Renaud Vitalis,et al.  rehh: an R package to detect footprints of selection in genome-wide SNP data from haplotype structure , 2012, Bioinform..

[44]  P. Newton,et al.  A Major Genome Region Underlying Artemisinin Resistance in Malaria , 2012, Science.

[45]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[46]  Nicholas J White,et al.  Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator , 2011, Malaria Journal.

[47]  Kevin Galinsky,et al.  Hybrid selection for sequencing pathogen genomes from clinical samples , 2011, Genome Biology.

[48]  Gonçalo R. Abecasis,et al.  The variant call format and VCFtools , 2011, Bioinform..

[49]  M. DePristo,et al.  A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.

[50]  Pedro M. Valero-Mora,et al.  ggplot2: Elegant Graphics for Data Analysis , 2010 .

[51]  Marissa A. LeBlanc,et al.  Surprising roles for phospholipid binding proteins revealed by high throughput genetics. , 2010, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[52]  Debashish Das,et al.  High heritability of malaria parasite clearance rate indicates a genetic basis for artemisinin resistance in western Cambodia. , 2010, The Journal of infectious diseases.

[53]  R. Price,et al.  In vivo parasitological measures of artemisinin susceptibility. , 2010, The Journal of infectious diseases.

[54]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[55]  Ian Sillitoe,et al.  The CATH Hierarchy Revisited—Structural Divergence in Domain Superfamilies and the Continuity of Fold Space , 2009, Structure.

[56]  K. Silamut,et al.  Artemisinin resistance in Plasmodium falciparum malaria. , 2009, The New England journal of medicine.

[57]  Paul Garner,et al.  Artemisinin-based combination therapy for treating uncomplicated malaria. , 2009, The Cochrane database of systematic reviews.

[58]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[59]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[60]  P. Newton,et al.  Adaptive Copy Number Evolution in Malaria Parasites , 2008, PLoS genetics.

[61]  X. Su,et al.  Genome-Wide Compensatory Changes Accompany Drug- Selected Mutations in the Plasmodium falciparum crt Gene , 2008, PloS one.

[62]  S. Elena,et al.  The evolution of sex: empirical insights into the roles of epistasis and drift , 2007, Nature Reviews Genetics.

[63]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[64]  Xiaoquan Wen,et al.  Correction: A Map of Recent Positive Selection in the Human Genome , 2006, PLoS Biology.

[65]  J. Pritchard,et al.  A Map of Recent Positive Selection in the Human Genome , 2006, PLoS biology.

[66]  Weltgesundheitsorganisation.  World malaria report , 2005 .

[67]  Carl T. Bergstrom,et al.  Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[68]  B. Sharp,et al.  Intercontinental Spread of Pyrimethamine-Resistant Malaria , 2004, Science.

[69]  J. Kublin,et al.  Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. , 2003, The Journal of infectious diseases.

[70]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[71]  L. Cowen,et al.  Divergence in Fitness and Evolution of Drug Resistance in Experimental Populations of Candida albicans , 2001, Journal of bacteriology.

[72]  M. Kollef.  Is there a role for antibiotic cycling in the intensive care unit? , 2001, Critical care medicine.

[73]  B. Levin,et al.  Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. , 2000, Genetics.

[74]  D. Andersson,et al.  Virulence of antibiotic-resistant Salmonella typhimurium. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[76]  D Payne,et al.  Spread of chloroquine resistance in Plasmodium falciparum. , 1987, Parasitology today.

[77]  J. Mcgowan.  Minimizing Antimicrobial Resistance in Hospital Bacteria: Can Switching or Cycling Drugs Help? , 1986, Infection Control.

[78]  L. Miller.  Current prospects and problems for a malaria vaccine. , 1977, The Journal of infectious diseases.